Document is current
Any future updates will be listed below
-
Authors
Yala, Adam
Hughes, Kevin S.
- License Information
-
More Information
Article History
Received: 15 June 2023
Accepted: 31 July 2023
First Online: 13 August 2023
Disclosure
: Kevin Hughes Honoraria: Receives Honoraria from TME (Targeted Medical Education, genetics education and consulting), MedNeon-Invitae (Genetic testing/education subdivision) 23&Me(Genetics company), Invitae(Genetics company), Ambry (Genetic testing) and Astra Zeneca (Parmaceutical Company) Financial Interest: Has a founded and has a financial interest in CRA Health (Formerly Hughes RiskApps) which was acquired by Volpara in January, 2021. CRA Health develops risk assessment models/software with a particular focus on breast cancer and colorectal cancer. Dr. Hughes is the Co-Creator of Ask2Me.Org which is freely available for clinical use and is licensed for commercial use by the Dana Farber Cancer Institute and the Massachusetts General Hospital (MGH). Dr. Hughes’s interests in CRA Health and Ask2Me.Org were reviewed and are managed by Massachusetts General Hospital and Mass General-Brigham in accordance with their conflict of interest policies.
Free to read: This content has been made available to all.
